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Metal Mutagenesis in Transgenic Chinese
Hamster Cell Lines
Catherine B. Klein, Biserka Kargacin, Lin Su, Sofia Cosentino,
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Metals are toxic agents for which genotoxic effects are often difficult to demonstrate. To study metal mutagenesis, we have used two stable hprt
gpte transgenic cell lines that were derived from Chinese hamster V79 cells. Both the G12 and Gl0 cell lines are known to be very sensitive to clas-
togens such as X-rays and bleomycin, with the mutagenic response of the integrated xanthine guanine phosphoribosyl transferase (gp) gene in G10
usually exceeding that of the same gene in the transgenic G12 cells. In studies with carcinogenic insoluble nickel compounds, a high level of muta-
genesis was found at the gpt locus of G12 cells but not at the endogenous hypoxanthine phosphoribosyl transferase (hpr locus of V79 cells. We
have since demonstrated the similar recovery of a high frequency of viable G12 mutants with other insoluble nickel salts including nickel oxides
(black and green). The relative mutant yield for the insoluble nickel compounds (G12>G10) is the opposite of that obtained with nonmetal clastogens
(G10>G12). In the G12 cells, nickel mutagenesis may be related to the integration of the gpt sequence into a heterochromatic region of the
genome. For some of the insoluble nickel compounds, significant inhibition of both cytotoxicity and mutant yield resulted when the G12 cells were
pretreated with vitamin E. In comparison with the nickel studies, the mutagenic responses to chromium compounds in these cell lines were not as
dramatic. Mutagenesis of the gpt target could not be demonstrated with other metals such as mercury or vanadium. - Environ Health Perspect
102(Suppl 3):63-67 (1994).
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Introduction
For many metals, toxicity, genotoxicity,
and carcinogenicity have been readily
established. To define the mechanisms that
produce these deleterious effects, gene-spe-
cific mutation analysis can be particularly
useful. With metals, however, it has often
been difficult to obtain mammalian muta-
genesis levels that are high enough to allow
definition ofthe mutagenic spectra. Nickel
compounds, for example, are generally
weak mutagens in mammalian cells (1-4)
In comparison, mutagenesis can usually be
demonstrated for chromium compounds in
most bacterial and mammalian cell sys-
tems; however, chromium does not elicit a
high mutagenic response at the hprt gene in
Chinese hamster V79 cells (5,6).
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One of the rationales for developing
transgenic V79 cell lines was to enhance
our ability to detect and characterize gene-
specific, metal-induced mutations. It was
known that integrated plasmid-derived
shuttle vector sequences were often more
mutable than endogenous mammalian
genes such as hprt (7,8). Additionally, the
introduction ofa small bacterial gene target
into Chinese hamster V79 cells could pro-
vide a readily recoverable mutagenesis tar-
get sequence (7). This would facilitate
mutation analysis by molecular methods
induding PCR and DNA sequencing. The
enzyme encoded by the E. coli gpt gene is
functionally equivalent to the enzyme pro-
duced by the mammalian hprt gene. The
bacterial gptgene has previously been intro-
duced into several mammalian host cell
lines, generating transgenic cells which
have been very useful in mutagenesis stud-
ies (9-12). Prior to the transfection ofthe
pSV2gptplasmid into our Chinese hamster
V79 cells, these host cells were mutated by
UV to generate an irreversible hprr phe-
notype. The successful recovery of numer-
ous stable gpt+ transfectants of V79 cells
was subsequently described (13).
Two hprv/gpt+ transgenic V79 cell
lines, G12 and G10, have since been char-
acterized in extensive mutagenesis studies
(13,14). Each ofthese cell lines maintains
a single integration site for the plasmid
sequence in different locations of the
Chinese hamster genome. Both the G12
and G10 cell lines have been shown to be
very sensitive to clastogens such as X-rays
and bleomycin, and the mutagenic
response ofthe integrated gptgene in G10
is greater than that ofthe same gene in the
transgenic G12 cells (14). For both cell
lines, X-ray mutagenesis of the integrated
gptlocus exceeds that which can be recov-
ered at the endogenous hprt locus of the
parental Chinese hamster V79 cells. These
cell lines are not generally hypermutable,
however, as demonstrated by spontaneous
and alkylation mutagenesis of the endoge-
nous Na+K+/ATPase locus (14). Having
established the utility ofthe transgenic cell
lines for mutagenesis studies, the G12 and
G10 cells were employed to investigate
whether significant levels ofgpt mutagene-
sis could be induced by carcinogenic and
toxic metals. This manuscript summarizes
data that was obtained from our studies of
several metals, including soluble and insol-
uble nickel compounds, chromate, vana-
dium, and mercury.
Materials and Methods
Celi CWukre
The hprt/lgpt+ transgenic cell lines G12
and GIO, and the parental Chinese ham-
ster V79 cells, are cultured in F12 medium
(GIBCO, Grand Island, NY) with 5% fetal
bovine serum (GIBCO) and 1% peni-
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cillin/streptomycin (GIBCO) at 37'C and
5% CO2 (13,14). To ensure low sponta-
neous mutagenesis levels, the G12 and
G10 cultures are initiated every 6 weeks
from frozen stocks and are supplemented
with HAT (100 pM hypoxanthine, 1 pM
aminopterin, 100 pM thymidine). V79
cells are also frequently defrosted, but are
not supplemented with HAT.
Mutagenesis
The mutagenesis protocol for detecting 6-
thioguanine (6-TG) resistance as an indica-
tor of genetic alteration or nonexpression
of the gpt gene in the transgenic cell lines
has been previously reported (13,14). The
protocol is a standard reseeding assay
which is essentially similar to that used to
detect hprt- mutants among V79 cells.
Optimum mutant yields can be obtained
when the treated cells are reseeded into
selection media (F12 with 10 pg/ml 6-TG)
6 days after treatment, and the mutants are
permitted to grow for an additional 13
days. The reseeding plating efficiency is
also determined at this time, by seeding a
small number of cells into F12 without 6-
TG. At the end ofthe selection period, the
mutants are simultaneously fixed and
stained with Giemsa (50% Giemsa solu-
tion, 50% methanol). Mutant frequencies
are calculated by totaling the number of
mutants obtained on 10 mutagenesis plates
per metal dose, and dividing that number
by the reseeding plating efficiency of each
treated and recovered population of cells.
The cytotoxicity ofeach treatment is mea-
sured by a colony-forming assay in which
300 or 500 cells are seeded in triplicate in
60 mm dishes. Following cell attachment,
the cells are treated, rinsed, supplemented
with fresh F12, and allowed to grow undis-
turbed for 7 days before staining and
counting.
Nickel mutagenesis studies were per-
formed as previously described (15).
Briefly, V79 cells and the transgenic cells
were exposed to sterilized, ground (<5 pm)
particles of insoluble nickel compounds
(nickel sulfide, nickel subsulfide, nickel
oxides; INCO, Ltd., Toronto, Ontario) for
24 hr in complete media. The nickel doses
are expressed as pg nickel/cm2 surface area
of the tissue culture dishes, since these
insoluble particles tend to settle out during
the 24-hr treatment (16,17). The nickel
doses chosen for the mutagenesis studies
were determined by preliminary cytotoxic-
ity studies, such that all the different nickel
compounds were investigated at generally
equitoxic dose ranges. As a positive muta-
genesis control, N-methyl-NM-nitro-N-
nitrosoguanidine (MNNG, Sigma
Chemical Co., St. Louis, MO) was rou-
tinely used. Potassium chromate (K2CrO4,
Fisher Scientific, Chemical Division, Fair
Lawn, NJ) treatments were for 2 to 5 hr
(18), at 37°C in either Earle's Balanced
Salt Solution (EBSS; GIBCO,Grand
Island, NY) or magnesium-supplemented
salts glucose media (50 mM HEPES
buffer, 100 mM NaCl, 5 mM KCI, 2 mM
CaCl2, 0.8 mM MgSO4, pH 7.2). With
chromium oxide (Fisher), the cells were
exposed 1-6 pM Cr03 for 24 hr in com-
plete media. Vanadium exposures were
with ammonium metavanadate, NH4VO3
U.T. Baker Chemicals, Phillipsburg, NJ),
for 2 or 24 hr in serum-free F12, SGM, or
EBSS as previously reported (5). For the
mercury studies, V79, G12, and GIO cells
were treated with 3 to 50 pg/mL mercuric
chloride (Sigma Chemical Co.) or methyl
mercury(II) chloride (Johnson Matthey
Electronics, Ward Hill, MA) for 2 hr in
EBSS.
Results and Discussion
In preliminary studies with nickel com-
pounds, a high level of6-TG was found to
be induced in G12 cells with insoluble
nickel sulfide (NiS) but not with soluble
nickel sulfate (NiSO4) (16). These com-
pounds were not mutagenic at the hprt
locus of the parental V79 cells. In another
study, a high level ofgpt mutagenesis was
also found with insoluble Ni3S2 in G12
cells (17). We have since confirmed these
findings, and have recently shown similar
levels of induction of 6-TG resistance fol-
lowing the exposure ofG12 cells to insolu-
ble nickel oxides (15). We have also
investigated the nickel-induced response of
the integrated gptgene in the GO0 cell line.
Figure 1 shows that the cytotoxicity ofNiS
is similar for the two transgenic cell lines,
G12 and G10. These data agree with those
from our studies with X-rays, bleomycin,
UV, and MNNG (14) in which large cell-
line differences in cytotoxicity are not gen-
erally observed, whereas the site of gpt
integration and its mutability differ.
Figure 2 compares the relative toxicity
of insoluble NiS and Ni3S2 in the G12
cells. We have studied all the nickel com-
pounds over essentially equitoxic dose
ranges (10-100% survival), and find that
much higher particle concentrations are
required for the nickel oxides than for the
nickel sulfides (Figures 3,4). Green nickel
oxide was significantly less toxic than the
black oxide particles. The high levels of
induction of6-TG resistance by nickel sul-
fide and subsulfide in G12 cells are shown
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Figure 1. NiS toxicity in G12 and G10 cells. Cytotoxicity
for insoluble NiS is shown for G12 (e) and G10 (A) cells,
as derived from one to three experiments per cell line
according to the protocol described in "Materials and
Methods." Standard errors of the mean are depicted by
errorbars in allfigureswhere sufficientdata exist.
in Figure 3A; while similar results with the
nickel oxides are shown in Figure 3B. With
soluble NiCl2, mutagenesis ofthe gptlocus
did not exceed 2 to 4 times the sponta-
neous levels in either G12 or GlO cells
(15). This is in agreement with the data
obtained previously for soluble NiSO4 in
G12 cells (16,17), and correlates well with
carcinogenicity studies in which the insolu-
ble nickel compounds are the most active
due to their phagocytic uptake (19). In our
studies with the G12 cells, we could micro-
scopically visualize phagocytized intracellu-
lar particles ofNiS and Ni3S2 at the end of
the 24-hr treatment, but could not see
phagocytized particles of NiO (15).
Although nickel oxide particles may not be
phagocytized as readily as the nickel sul-
fides (20), there are indications that these
particles may remain associated with the
cell membranes for long periods (21).
Since the treated cells are not disturbed in
our assay for up to 6 days after the end of
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Figure 2. NiS and Ni3S2 toxicity in G12 cells. Cytotoxicity
curves for two insoluble nickel compounds, NiS (-) and
Ni3S2(o), aredepicted. The datawere derivedfrom two or
three experiments per compound. For the mutagenesis
studies, all nickel compounds were studied overequitoxic
dose ranges yielding approximately 10 to 100% survival
as shown here.
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Rgure3 Mutagenesis of insoluble nickel compounds in G12 cells.
thegptlocus ofG12cells, is shown in Panel 3A. Mutagenesis is als
gptlocus ofGl2 cells in Panel 3B. The data were derived from twc
in dose rangesyielding 10to 100% cell survival isquite evidentfor
Table 1. Mutagenesis of gptin transgenic cell lines.
Mutagen Cell line
X-rays, 250-750cGy G12
GlO
Bleomycin, 1O-125 pg/ml, 1 hr G12
GlO
mAMSA, 1G-100 ng/ml, 3 hr G12
GlO
UV, 2-1OJ/M2 G12
GlO
30-
Bo I
- IT
appears to be localized within a heterochro-
matic region ofchromosome 1. In contrast,
localization studies of the gpt sequence in
G10 cells suggest a chromosomal position
which is neither chromosome 1 or X
(Klein, unpublished) and this location may
roo not be sensitive to transcription modula-
- | tion ofgpt gene expression in the same
// l manner as in G12 cells.
01t For some of the insoluble nickel com-
56.00 pounds, significantinhibition ofboth cyto-
Dose (pg/cm2) toxicity and mutant yield resulted when
the G12 cells were pretreated for 24 hr
Comparative mutagenesis ofNiS(-)and Ni S (o)at with a nontoxic (20 jM) dose ofvitamin E
,oshown forNi0(black)(.)andNi0(green)1fatthe (15). Vitamin E is an antioxidant, which is
Dto three experiments percompound. The difference capable of protecting cells against some of
the sulfidesversusthetwo oxides. the genotoxic effects of ionizing radiation
(26) and chemicals, including chromate
(6,27,28). Vitamin E was previously
shown to inhibit some nickel-induced
6-TG
IMutagenesisa(times background) chromosomal aberrations in Chinese ham-
18X ster ovary cells (29) and we have extended
32X those finding to demonstrate inhibition of
cytotoxicity and gpt mutagenesis in G12 8X cells (15). Enhanced cell survival was most
notable for NiS and NiO (black); and gpt
lox mutagenesis by NiS, Ni3S2, and NiO
15X (black) could be reduced by up to 50% at
some doses (data not shown). With soluble
lox NiCl2, significant vitamin E protection was lox not detected. These results suggests that
1alighest observed mutagenesis expressed as a function ofthe background mutagenesis foreach cell line(induced/spon-
taneous).
the treatment,, the opportunity exists for useful for defining the mechanisms of
prolonged cellular association ofthe nickel nickel carcinogenesis.
oxides. The transgenic G10 cells did not
What is the nature of these nickel- respond to the insoluble nickel compounds
induced mutants, and why do they arise at with the same intensity as seen above for
such a high frequency? Preliminary studies G12 cells (Figure 4), in contrast to our data
ofthe mutagenic alterations within the gpt with X-rays and bleomycin (14). Nickel
sequence of several 6-TG-resistant G12 mutagenesis could only be induced to
colonies have thus far failed to show base about three times that of the spontaneous
changes or deletions involving the coding frequency for the G10 cell line. The cell
region ofthegptgene (17). In studies with line differences in gpt mutagenesis are
another set of mutants, preliminary data clearly evident as summarized on the tables
strongly suggest that most of the nickel- for both nonmetal mutagens (Table 1) and
induced 6-TG-resistant colonies were vari- metals (Table 2). In the G12 cells, the
ants, whose phenotype could be reverted to nickel effects may be related to the integra-
6-TG sensitivity by subsequent treatment tion ofthe gptsequence into a heterochro-
with nickel or 5-azacytidine (22). Nickel matic region ofthe genome. The specificity
appears to be unique in this regard, since for nickel interactions with heterochro-
DNA sequence changes, as well as total or matin are well documented (19,24). Using
partial deletions of the gpt gene sequence, fluorescent in situhybridization ofa biotin-
among spontaneous, X-ray, bleomycin, and labeled gpt probe to the metaphase chro-
even chromate-induced 6-TG-resistant mosomes of G12 cells, we have localized
mutants of both G12 and G10 cells have the integrated gpt sequence to a subtelom-
been observed (14,23). In fact, the gpt eric region of chromosome 1 (25). Based
locus in the G12 cells may be an important on the C-banding pattern ofChinese ham-
nickel-sensitive locus, and studies of the ster V79 chromosomes (25), the gpt
modulation ofgpt gene expression may be sequence of the V79-derived G12 cells
tne process or pnagocytosos, ana tne ongo-
ing generation of reactive oxygen radicals,
may play important roles in nickel geno-
toxicity.
In comparison with the nickel studies,
the mutagenic responses to chromium
compounds in the transgenic cell lines were
not as dramatic. Relative to spontaneous
mutagenesis levels, the maximal chromate-
induced mutant yield is only three times
the background yield for both G12 and
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Figure 4. Mutagenesis of insoluble nickel compounds in
G10cells. MutagenesisofinsolubleNiS(A), Ni3S2(A), NiO
(black) (-), and NiO (green) (l) particles is compared at
the gptlocus of Gl0 cells. The data for NiS and NiO(black)
are the means of two independent experiments, while the
data for Ni3S2 and NiO (green) are derived from single
experiments. The different biologically effective dose
rangesforthesecompoundsareclearlyevident.
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Table2. Comparative metal mutagenesis in transgenic cell lines.
6-TGRmutagenesis
Mutagen Cells (timesbackground)a
Nickelsulfide,0.1-0.5 pg/cm2, 24hr G12 30x
G10 2x
Nickel subsulfide, 0.1-0.5 pg/cm2, 24 hr G12 40x
G10 3x
Nickel oxide(black), 0.6-1.8 pg/cm2, 24 hr G12 30x
G10 2x
Nickel oxide (green), 3.0-6.0 pg/cm2, 24 hr G12 40x
G10 3x
Nickel chloride, 200-600 pm, 24 hr G12 4x
G10 4x
Chromate, 5-30 pm, 2 hr G12 3 x
G10 3x
Vanadate, 5-40 pm, 24 hr G12 2x
G10 ND
Methyl mercury, 3-50 ng/ml, 1 hr G12 <2 x
G10 <lx
¶lighestobserved mutagenesis expressed as induced/spontaneous.
G10 cells following a 2-hr exposure to
potassium dichromate ( 5-30 pM). This
mutagenesis yield could be increased to five
or seven times the background levels, if-the
chromate treatment times were increased.
With chromium oxide, gpt mutagenesis
could be induced to about four times the
spontaneous levels in G12 cells, and was
slightly higher in some studies with G10
cells (S. Cosentino, unpublished).
Chromium mutagenesis studies, however,
are complicated for several reasons. We
have observed that the prolonged exposure
of attached cells to chromium compounds
often results in cellular detachment from
the treatment dishes (18). As a result, pre-
mutant cells are likely to be lost from the
chromium-treated populations. It is also
difficult to define an effective chromium
treatment dosing regime, since chromium
compounds are often mutagenic over a
very narrow dose range (5,6,18,28). This
may be partly related to residual toxicity
that could result from trivalent Cr that is
trapped within the cells (30). Residual
chromate toxicity, as indicated by reduced
plating efficiency, has been observed up to
one week after the treatment ofV79, G12
and G10 cells (18).
Mutagenesis of the gpt targets in G12
and GIO cells could not be demonstrated
with other metals such as mercury or vana-
dium. Figure 5 shows the toxicity and
mutagenesis data obtained in experiments
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Figure 5. Methyl mercury toxicity and mutagenesis in G12, G10 and V79 cells. The cytotoxicity (Figure 5a) of MeHg is
depicted forG12 (.), G10( o), and V79(A) cells. Mutagenesis could not be induced at eitherthe gptlocus of G12 (.) or
G10 (o) cells, or atthe hprtlocus of the parental V79 cells (A) as shown in Figure 5b. The data were derived from two
independentexperimentsforeachtransgeniccell line, anda single experimentwith W79cells.
with methyl mercury chloride. As noted in
Figure 5A, the G0 cells seem to exhibit a
slight resistance to the toxicity of this
agent. This effect has not been further
studied. Mutagenesis could not be induced
at the gptlocus ofeither G12 or G10 cells,
nor could it be demonstrated at the hprt
gene in the parental V79 cells. These find-
ings suggest that mercury compounds are
generally too toxic to permit cell survival as
required for mutagenesis, and are consis-
tent with the literature on mercury geno-
toxicity (31,32). In studies with vanadate
(Table 2), weak mutagenesis was demon-
strated at the hprtgene ofV79 cells, and at
the gpt locus of G12 cells, but was not
investigated with G10 cells (5).
In conclusion, metal mutagenesis is dif-
ficult to quantitate in mammalian cell sys-
tems. For most of the metal studies
summarized here, the level of induced gpt
mutagenesis was less than five times the
spontaneous frequency. The transgenic
G12 cell line, however, is sensitive to insol-
uble nickel compounds, and will be used in
future studies of nickel modulation of gpt
gene expression. These studies may ulti-
mately be useful in determining the mecha-
nisms involved in nickel carcinogenesis.
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